Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Figure 2. Recombinant protein microarray analysis.

Figure 2

Individual serum samples from ovarian cancer, benign ovarian disease and normal control donors were screened on a microarray containing recombinant autoantigens. Positive image for one of the autoantigen is shown.